Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Plexbio Co. Ltd. currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 2 actions are split between 2 distinct examiners and 2 distinct art units. HOBBS, MICHAEL L is identified as the busiest examiner with 1 pending office action. This 1:1 ratio between pending actions and examiners suggests a diversified prosecution across different technical sub-specialties or art units.
The 2 pending office actions are distributed across 2 distinct art units, indicating that the company is pursuing multiple technical paths within the Biotechnology & Pharmaceuticals sector. With 2 distinct examiners involved, the company must manage two separate prosecution timelines. HOBBS, MICHAEL L handles 1 pending office action, which is the same volume as the other examiner. This lack of concentration across 2 distinct examiners and 2 distinct art units means that the outcome of each of the 2 pending office actions is independent of the other.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOBBS, MICHAEL L | 1 | 68.7% | +28.4% |
| GORDON, BRIAN R | 1 | 65.3% | +19.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18386375 | AUTOMATIC SAMPLE PREPARATION SYSTEM | GORDON, BRIAN R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18516803 | MAGNETIC MICROCARRIERS FOR IMAGE DIFFERENTIATED MULTIPLEX ASSAYS | HOBBS, MICHAEL L | — |
| 18386375 | AUTOMATIC SAMPLE PREPARATION SYSTEM | GORDON, BRIAN R | — |
| Art Unit | Apps |
|---|---|
| 1672 | 1 |
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18516803 | MAGNETIC MICROCARRIERS FOR IMAGE DIFFERENTIATED MULTIPLEX ASSAYS | HOBBS, MICHAEL L | 1672 | §103 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18386375 | AUTOMATIC SAMPLE PREPARATION SYSTEM | GORDON, BRIAN R | 1798 | §103§112 | Final Rejection | — | Pending | Nov 02, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPlexbio Co. Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Michael L Hobbs has the most, with 1 of Plexbio Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
